Purple Biotech Says IM1240 Abstract Selected for Oral Presentation
The abstract is selected for an oral presentation at the 38th EORTC-NCI-AACR Symposium on November 20, 2026, at 15:00 CET.
Related stories
Intel Cites AI Server Demand Behind Q3 2026 Revenue Beat
Intel management cited AI-driven server demand as a driver of its Q3 2026 revenue beat.
M impact | EQUITY | Oct 29, 2026, 10:15 PM UTC
Bunge publishes Q3 2026 earnings call transcript
Bunge published its third-quarter 2026 earnings call transcript.
M impact | EQUITY | Oct 29, 2026, 10:15 PM UTC
Ganzhou Hemay Pharmaceutical: trading in H shares on Hong Kong stock exchange set to begin Nov. 9
L impact | EQUITY | Oct 29, 2026, 10:12 PM UTC
Ganzhou Hemay Pharmaceutical: global offering to include 55.2 million H shares
L impact | EQUITY | Oct 29, 2026, 10:11 PM UTC
Jiangsu Xinde Semiconductor Technology: number of offered shares in global offering 106.6 million H shares
L impact | EQUITY | Oct 29, 2026, 10:10 PM UTC
Suzhou Denglin Technology: dealings in H shares on stock exchange expected to start Nov. 10
L impact | EQUITY | Oct 29, 2026, 10:06 PM UTC